New Immunotherapy Treatment Could Lead to Better, Cheaper Results for Pancreatic Cancer
A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.
Patients in a trial who received the new treatment, IMM-101 with chemotherapy, showed a significant survival advantage over those receiving chemotherapy alone. Most importantly, the combination resulted in no added toxicity for the recipients, unlike many other cancer treatments.
Immunotherapy treatments help to boost the immune system, enabling it to deal effectively with cancer cells. Read more . . .
